IMNM logo

Immunome, Inc. (IMNM) Cash and Cash Equivalents

Annual Cash & Cash Equivalents:

$143.35M+$44.67M(+45.27%)
December 31, 2024

Summary

  • As of today, IMNM annual cash & cash equivalents is $143.35 million, with the most recent change of +$44.67 million (+45.27%) on December 31, 2024.
  • During the last 3 years, IMNM annual cash & cash equivalents has risen by +$94.12 million (+191.19%).
  • IMNM annual cash & cash equivalents is now at all-time high.

Performance

IMNM Cash and Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMbalance sheet metrics

Quarterly Cash & Cash Equivalents:

$268.04M-$49.29M(-15.53%)
June 30, 2025

Summary

  • As of today, IMNM quarterly cash & cash equivalents is $268.04 million, with the most recent change of -$49.29 million (-15.53%) on June 30, 2025.
  • Over the past year, IMNM quarterly cash & cash equivalents has dropped by -$10.32 million (-3.71%).
  • IMNM quarterly cash & cash equivalents is now -15.53% below its all-time high of $317.32 million, reached on March 31, 2025.

Performance

IMNM Quarterly Cash & Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMbalance sheet metrics

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

IMNM Cash and Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+45.3%-3.7%
3Y3 Years+191.2%+673.6%
5Y5 Years+5537.1%+2638.1%

IMNM Cash and Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+605.4%-15.5%+1218.9%
5Y5-Yearat high+5537.1%-15.5%+3874.4%
All-TimeAll-Timeat high+8848.3%-15.5%>+9999.0%

IMNM Cash and Cash Equivalents History

DateAnnualQuarterly
Jun 2025
-
$268.04M(-15.5%)
Mar 2025
-
$317.32M(+46.0%)
Dec 2024
$143.35M(+45.3%)
$217.30M(-9.5%)
Sep 2024
-
$240.13M(-13.7%)
Jun 2024
-
$278.35M(-10.1%)
Mar 2024
-
$309.71M(+124.2%)
Dec 2023
$98.68M(+385.6%)
$138.14M(+52.4%)
Sep 2023
-
$90.64M(+135.9%)
Jun 2023
-
$38.42M(-13.5%)
Mar 2023
-
$44.42M(+118.6%)
Dec 2022
$20.32M
$20.32M(-24.9%)
DateAnnualQuarterly
Sep 2022
-
$27.08M(-21.9%)
Jun 2022
-
$34.65M(-19.2%)
Mar 2022
-
$42.88M(-12.9%)
Dec 2021
$49.23M(+23.8%)
$49.23M(-12.5%)
Sep 2021
-
$56.24M(-6.0%)
Jun 2021
-
$59.83M(+64.9%)
Mar 2021
-
$36.28M(-8.8%)
Dec 2020
$39.77M(+1463.7%)
$39.77M(+489.7%)
Sep 2020
-
$6.74M(-31.1%)
Jun 2020
-
$9.79M(+284.9%)
Dec 2019
$2.54M(+58.7%)
$2.54M
Dec 2018
$1.60M
-

FAQ

  • What is Immunome, Inc. annual cash & cash equivalents?
  • What is the all-time high annual cash & cash equivalents for Immunome, Inc.?
  • What is Immunome, Inc. annual cash & cash equivalents year-on-year change?
  • What is Immunome, Inc. quarterly cash & cash equivalents?
  • What is the all-time high quarterly cash & cash equivalents for Immunome, Inc.?
  • What is Immunome, Inc. quarterly cash & cash equivalents year-on-year change?

What is Immunome, Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of IMNM is $143.35M

What is the all-time high annual cash & cash equivalents for Immunome, Inc.?

Immunome, Inc. all-time high annual cash & cash equivalents is $143.35M

What is Immunome, Inc. annual cash & cash equivalents year-on-year change?

Over the past year, IMNM annual cash & cash equivalents has changed by +$44.67M (+45.27%)

What is Immunome, Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of IMNM is $268.04M

What is the all-time high quarterly cash & cash equivalents for Immunome, Inc.?

Immunome, Inc. all-time high quarterly cash & cash equivalents is $317.32M

What is Immunome, Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, IMNM quarterly cash & cash equivalents has changed by -$10.32M (-3.71%)
On this page